Browsing Tag
WEE1 inhibitor
1 post
Biomarker promise or clinical reality: What ASPENOVA will prove or disprove
Can ASPENOVA validate biomarker-driven ovarian cancer therapy? Discover what Zentalis Pharmaceuticals, Inc.’s strategy means for the industry.